Article

Wilmer Eye Institute breaks ground for new building

Baltimore-The Wilmer Eye Institute of Johns Hopkins University School of Medicine broke ground June 6 for a $100 million, 200,000-square-foot structure to house additional research and clinical facilities across the street from the institute’s current facility.

Baltimore-The Wilmer Eye Institute of Johns Hopkins University School of Medicine broke ground June 6 for a $100 million, 200,000-square-foot structure to house additional research and clinical facilities across the street from the institute’s current facility.

The new building, scheduled to be completed by 2009, will feature a multi-story glass atrium; a surgical center outfitted with diagnostic, imaging, and documentation equipment; and open laboratory space to foster collaboration.

“The aim is to get scientists to work closely with one another; share ideas, equipment, and expertise; and have great flexibility in creating needed research space,” said Peter J. McDonnell, MD, director of the institute and the William Holland Wilmer Professor of Ophthalmology.

The institute’s faculty of 80 currently conducts $25 million worth of federal and other research and performs more than 8,000 major inpatient and outpatient eye surgeries each year. The new facility is expected to increase access to meet a projected demand for more than 9,000 annual operations.

The new building is part of a $1.2 billion medical campus redevelopment program at Johns Hopkins that is designed to replace aging structures on the 80-acre campus. The centerpieces of the redevelopment are two new clinical towers, one for cardiovascular and critical care services and one for a children’s hospital.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.